February 25, 2020 (Owings Mills, MD) — A recently introduced bill, HB-852, would remove cost-sharing for prostate cancer screening in Maryland. Specifically, the legislation requires coverage for digital rectal exam and PSA testing for men between 40 and 75 years old and those at high risk of developing the disease. On February 13, 2020, the Maryland House of Delegates heard testimony from Chesapeake Urology’s Director of Prostate Cancer Care, Dr. Ben Lowentritt. “This is about incorporating prostate cancer screening in a preventive measure in a well visit or physical exam that may be covered under a plan,” Dr. Lowentritt testified.
On February 26, Dr. Alan Kaplan testified before the Maryland Senate in support of the legislation as well. “For many Marylanders, the financial burden of prostate cancer screening is too heavy to bear; removing those barriers is a small but critical step toward access to high-quality care in our state,” he said in his testimony.
The bill was formally endorsed by the American Urological Association, ZERO – The End of Prostate Cancer, Chesapeake Urology, and MedChi: The Maryland State Medical Society. HB-852 now awaits further consideration by the Maryland House of Delegates and Senate. Chesapeake Urology is committed to advocating for better access to high-quality urological care within our communities and in Washington, D.C.